✉news ScienceScience first seen 2 d ago, last 2 d ago, peak #31
Experimental Vaccine Targets Gene Driving Most Pancreatic Cancers
Original: A New Experimental Vaccine Targets Rogue Genes Linked To 90 Percent Of Pancreatic Cancers
An experimental vaccine is being developed to target mutations in a gene linked to roughly 90 percent of pancreatic cancers, one of the deadliest and hardest-to-treat cancers. The approach aims to train the immune system to recognize and attack tumor cells carrying the rogue gene. Details on clinical trials and results remain limited, but the news is drawing attention as a potential advance against a cancer with very poor survival rates.
Why now: News of a vaccine approach against the most common pancreatic cancer mutation offers hope against a cancer with notoriously low survival rates.
pancreatic cancerKRAS genevaccine
Rank over time, top of the chart is #1. 2 snapshots from 2 d ago to 2 d ago.
Evidence
- A New Experimental Vaccine Targets Rogue Genes Linked To 90 Percent Of Pancreatic Cancers · IFLScience
API: https://socialmediatrends-api.osmike.com/v1/trends/4773075